(lp0
S"Here's Why Merrimack Pharmaceuticals Inc. Fell 47.3% in 2016 Motley Fool - Jan 9, 2017 While 2016 was a rough period for the biotech industry in general, shareholders of Merrimack Pharmaceuticals  had to suffer through an especially brutal period.Merrimack Concludes Strategic Review; Announces Plan to Divest Assets and ... - PR Newswire Merrimack Pharmaceuticals Inc  Stock Soars on Ipsen Deal - Investorplace.com"
p1
aS"Company Update : Merrimack Pharmaceuticals Inc Announces 4Q and ... Smarter Analyst - Mar 1, 2017 Merrimack Pharmaceuticals, Inc. engages in discovering, developing and preparing to commercialize innovative medicines consisting of novel therapeutics paired with diagnostics for the treatment of cancer.Merrimack Pharmaceuticals Inc.: Merrimack Reports Fourth Quarter and Full-Year ... - The Wall Street TranscriptEarnings in focus: Merrimack Pharmaceuticals, Inc. 's track record - Post Analyst"
p2
aS'Why Merrimack Pharmaceuticals Got Crushed 23.8% in January Motley Fool - Feb 6, 2017 Last October, Merrimack Pharmaceuticals jettisoned its CEO and announced a 20% workforce reduction because of mounting expenses, and in December, the company was forced to shutter development of a once-promising breast cancer treatment after it&nbsp;...Momentum Stock in Concentration: Merrimack Pharmaceuticals, Inc.  - TopChronicle'
p3
aS'Stock Returns: INSYS Therapeutics Inc  is Beating Merrimack ... CML News - 10 hours ago This is a snapshot to compare the stock returns for INSYS Therapeutics Inc  versus Merrimack Pharmaceuticals Inc  . The stock return points we compare look at the last three-months, six-months and twelve-months.'
p4
aS'Earnings Reaction History: Merrimack Pharmaceuticals Inc, 36.4% Follow-Through ... Nasdaq - Mar 1, 2017 Merrimack Pharmaceuticals Inc  is due to issue its quarterly earnings report in the upcoming extended-hours session.'
p5
aS'Merrimack Pharmaceuticals Inc.  Moves Lower on Volume Spike for March 17 Equities.com - Mar 17, 2017 Merrimack Pharmaceuticals Inc.  traded on unusually high volume on Mar. 17, as the stock lost 3.6% to close at $3.21.Fmr LLC Boosts Stake in Merrimack Pharmaceuticals Inc  - Chaffey BreezeMerrimack Pharmaceuticals  Stock: Gaining On Takeover Rumors - CNA Finance '
p6
aS"Merrimack Pharmaceuticals, Inc.  hit its 52 Week low of $2.83 on Jan 23 ... The Newburgh Press - 17 hours ago The 2 analysts offering 12-month price forecasts for Merrimack Pharmaceuticals Inc have a median target of 9.00, with a high estimate of 15.00 and a low estimate of 3.00.Are Merrimack Pharmaceuticals, Inc.  Stock Technicals Favorable? - USA Commerce DailyStock on Trader's Radar: Merrimack Pharmaceuticals, Inc.  - TopChronicle"
p7
aS'Chart Watch: Checking on Shares of Merrimack Pharmaceuticals Inc  Davidson Register - 16 hours ago Technical traders have a large inventory of technical indicators they may use when doing technical stock analysis. After a recent look, the 14-day ATR for Merrimack Pharmaceuticals Inc  is resting at 0.14. First developed by J. Welles Wilder, the ...'
p8
aS'Merrimack Pharmaceuticals Inc.: Merrimack Announces Timing of Fourth Quarter ... The Wall Street Transcript - Feb 22, 2017 CAMBRIDGE, Mass., Feb. 22, 2017 /PRNewswire/ -- Merrimack Pharmaceuticals, Inc.  today announced that the company will host its Fourth Quarter 2016 investor conference call and webcast at 8:30 a.m.Merrimack Pharmaceuticals, Inc.  Scheduled to Post Earnings on Thursday - The Cerbat GemBiotech Stocks Worth a Closer Look: Merrimack Pharmaceuticals, Inc. (NASDAQ ... - The Voice Registrar'
p9
aS'Merrimack Pharmaceuticals Inc.  Plunges 5.26% on March 07 Equities.com - Mar 7, 2017 Merrimack Pharmaceuticals Inc.  had a rough trading day for Tuesday March 07 as shares tumbled 5.26%, or a loss of $-0.17 per share, to close at $3.06.Merrimack Pharmaceuticals, Inc. : Important Trade and Target Levels To Watch - Post AnalystMerrimack Pharmaceuticals Inc  Receives Consensus Recommendation of Buy ... - Chaffey Breeze'
p10
a.